BIOCRYST SCHEDULED TO PRESENT AT NEEDHAM & COMPANY BIOTECHNOLOGY CONFERENCE
Birmingham, Alabama - May 18, 2005 - BioCryst Pharmaceuticals, Inc. (Nasdaq NM: BCRX) announced that Charles E. Bugg, Ph.D., Chairman and CEO, will be presenting at The Fourth Annual Needham & Company Biotechnology Conference on Wednesday, May 25, 2005, at 2:00 p.m. ET. Interested investors can listen to the presentation live over the Internet during the conferences at the following addresses:
What: BioCryst Pharmaceuticals, Inc. Presentation at The Fourth Annual Needham & Company Biotechnology Conference
When: Wednesday, May 25, 2005, at 2:00 p.m. ET
Where: http://www.wsw.com/webcast/needham11/bcrx/
How: Live over the Internet -- Simply log on to the web at the address above
For those unable to listen at the designated time, the webcast will remain available for replay for 90 days following the conferences.
Founded in 1986, BioCryst Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of small-molecule pharmaceuticals to treat cancer, cardiovascular and autoimmune diseases, and viral infections.
Contacts:
BioCryst Pharmaceuticals, Inc.
Mike Darwin
Chief Financial Officer
(205) 444-4600
Noonan/Russo
Sharon Weinstein (Investors)
(212) 845-4271
Wendy Lau (Media)
(212) 845-4272